782 related articles for article (PubMed ID: 16154634)
1. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
2. Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
Obuchowicz E; Herman ZS
Neuropeptides; 2003 Feb; 37(1):17-24. PubMed ID: 12637031
[TBL] [Abstract][Full Text] [Related]
3. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
Schröder U; Schröder H; Augustin W; Sabel BA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
[TBL] [Abstract][Full Text] [Related]
4. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine-induced effects on neuropeptide Y in the rat brain.
Obuchowicz E; Turchan J; Przewłocki R; Herman ZS
Pharmacol Rep; 2005; 57(3):321-9. PubMed ID: 15985714
[TBL] [Abstract][Full Text] [Related]
6. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
7. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
[TBL] [Abstract][Full Text] [Related]
8. Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.
Obuchowicz E; Turchan J
Neuropeptides; 1998 Oct; 32(5):473-80. PubMed ID: 9845010
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Gruber SH; Nomikos GG; Mathé AA
Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
Obuchowicz E; Turchan J
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):51-9. PubMed ID: 10082228
[TBL] [Abstract][Full Text] [Related]
11. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
Mao L; Wang JQ
Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
[TBL] [Abstract][Full Text] [Related]
12. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
[TBL] [Abstract][Full Text] [Related]
13. Developmental striatal critical period of activity-dependent plasticity is also a window of susceptibility for haloperidol induced adult motor alterations.
Soiza-Reilly M; Azcurra JM
Neurotoxicol Teratol; 2009; 31(4):191-7. PubMed ID: 19336253
[TBL] [Abstract][Full Text] [Related]
14. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.
Le Foll B; Diaz J; Sokoloff P
Synapse; 2003 Mar; 47(3):176-83. PubMed ID: 12494400
[TBL] [Abstract][Full Text] [Related]
15. The effects of haloperidol on dopamine receptor gene expression.
Fox CA; Mansour A; Watson SJ
Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
[TBL] [Abstract][Full Text] [Related]
16. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice.
Akhisaroglu M; Kurtuncu M; Manev H; Uz T
Pharmacol Biochem Behav; 2005 Mar; 80(3):371-7. PubMed ID: 15740778
[TBL] [Abstract][Full Text] [Related]
17. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
18. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors.
Robertson GS; Lee CJ; Sridhar K; Nakabeppu Y; Cheng M; Wang YM; Caron MG
Eur J Neurosci; 2004 Dec; 20(11):3189-94. PubMed ID: 15579174
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala.
Smiałowska M; Bajkowska M; Heilig M; Obuchowicz E; Turchan J; Maj M; Przewłocki R
Neuropeptides; 2001 Apr; 35(2):82-91. PubMed ID: 11384203
[TBL] [Abstract][Full Text] [Related]
20. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice.
Tammimäki A; Pietilä K; Raattamaa H; Ahtee L
Eur J Pharmacol; 2006 Feb; 531(1-3):118-25. PubMed ID: 16442094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]